EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

PIK3C2A ‐Related Clinical Phenotype and Cellular Charaterization Linked to Functional SHH Primary Cilia Defect

Adella Karam, Clarisse Delvallée, Bénédicte Gérard, Elodie Javey iD, Pascal Kessler, Valérie Pelletier, Jean-Baptiste Lamouche, Nicolas Le May, Jean Muller iD, Hélène Dollfus

Clinical Genetics · 2025-12 · 108 (6) · 696-707

DOI: 10.1111/cge.70005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Genetics, online erschienen am 21.06.2025. Verfasst von Adella Karam und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire de Génétique médicale, UMR_S INSERM U1112, Institut de Génétique Médicale D'alsace (IGMA), Université de Strasbourg, Strasbourg, France. Hauptthemen laut MEDLINE: Phosphatidylinositol 3-Kinases, Abnormalities, Multiple, Musculoskeletal Diseases, Eye Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Université de Strasbourg, Agence de la Biomédecine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PIK3C2A is a member of the class II phosphatidylinositol‐3‐kinases (PI3K) family that catalyzes the phosphorylation of phosphatidylinositol (PI) into PI(3)P and of PI(4)P into PI(3,4)P2. These second messenger lipids regulate a wide range of downstream signaling pathways involved in many physiological functions and cellular processes, including cell proliferation, growth, survival, motility, and metabolism. PIK3C2A is also involved in the regulation of primary cilia formation and maintenance and in the regulation of receptor‐mediated endocytosis at the base of the cilium. PIK3C2A was recently related to a novel oculoskeletodental syndrome (OCSKD MIM#618440), combining short stature, coarse facial features, ocular, and skeletal abnormalities. We describe here the fifth family presenting a PIK3C2A ‐related syndrome characterized by pulverulent cataracts and deafness. Using trio exome sequencing, we identified two novel compound heterozygous variants in PIK3C2A for which functional testing was necessary to assess the effect of one of the variants. Cellular studies of patient's‐derived skin fibroblasts revealed a normal PIK3C2A protein level but a defective enzyme. Ciliary and cellular phenotype studies showed in the patient's cells impaired cilia formation and function as well as a reduced proliferative capacity. This study expands the clinical and mutational spectrum of PIK3C2A ‐related syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phosphatidylinositol 3-KinasesAbnormalities, MultipleMusculoskeletal DiseasesEye DiseasesHumansMaleFemalePedigreeGenetic VariationPhosphatidylinositolsCiliaCell ProliferationGenes, Recessive

Stichwörter der Autor:innen

PIK3C2API metabolism disordersprimary ciliumsonic hedgehog pathway

Substanzen

PIK3C2A protein, humanPhosphatidylinositol 3-KinasesPhosphatidylinositols

Autor:innen und Institutionen

  • Laboratoire de Génétique médicale, UMR_S INSERM U1112, Institut de Génétique Médicale D'alsace (IGMA), Université de Strasbourg, Strasbourg, France.
  • Laboratoires de Diagnostic Génétique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Université de Strasbourg, Inserm UMS 38, Centre de Recherche en Biomédecine de Strasbourg, Faculté de Médecine, Strasbourg, France.
  • Centre de Référence Pour les Affections Rares en génétique Ophtalmologique, CRMR CARGO, Filière SENSGENE (FSMR), Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Unité Fonctionnelle de Bioinformatique Médicale appliquée Au Diagnostic (UF7363), Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Service de Génétique Médicale, Institut de Génétique Médicale D'alsace (IGMA), Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

ORCID-Profile: Elodie Javey, Jean Muller

Förderung

  • Université de Strasbourg
  • Agence de la Biomédecine

Zitieren

APA

Karam, A., Delvallée, C., Gérard, B., Javey, E., Kessler, P., Pelletier, V., Lamouche, J. B., Le May, N., Muller, J., & Dollfus, H. (2025). PIK3C2A ‐Related Clinical Phenotype and Cellular Charaterization Linked to Functional SHH Primary Cilia Defect. Clinical Genetics, 108(6), 696-707. https://doi.org/10.1111/cge.70005

Vancouver

Karam A, Delvallée C, Gérard B, Javey E, Kessler P, Pelletier V, et al. PIK3C2A ‐Related Clinical Phenotype and Cellular Charaterization Linked to Functional SHH Primary Cilia Defect. Clinical Genetics. 2025;108(6):696-707. doi:10.1111/cge.70005

BibTeX
@article{Karam2025,
  author = {Karam, Adella and Delvallée, Clarisse and Gérard, Bénédicte and Javey, Elodie and Kessler, Pascal and Pelletier, Valérie and Lamouche, Jean-Baptiste and Le May, Nicolas and Muller, Jean and Dollfus, Hélène},
  title = {PIK3C2A ‐Related Clinical Phenotype and Cellular Charaterization Linked to Functional SHH Primary Cilia Defect},
  journal = {Clinical Genetics},
  year = {2025},
  volume = {108},
  number = {6},
  pages = {696--707},
  doi = {10.1111/cge.70005}
}
Kostenlos starten →